| Literature DB >> 26284034 |
Fernanda P Claverías1, Agustina Undabarrena1, Myriam González1, Michael Seeger1, Beatriz Cámara1.
Abstract
Marine-derived Actinobacteria are a source of a broad variety of secondary metabolites with diverse biological activities, such as antibiotics and antitumorals; many of which have been developed for clinical use. Rare Actinobacteria represent an untapped source of new bioactive compounds that have been scarcely recognized. In this study, rare Actinobacteria from marine sediments were isolated from the Valparaíso bay, Chile, and their potential to produce antibacterial compounds was evaluated. Different culture conditions and selective media that select the growth of Actinobacteria were used leading to the isolation of 68 bacterial strains. Comparative analysis of the 16S rRNA gene sequences led to identifying isolates that belong to the phylum Actinobacteria with genetic affiliations to 17 genera: Aeromicrobium, Agrococcus, Arthrobacter, Brachybacterium, Corynebacterium, Dietzia, Flaviflexus, Gordonia, Isoptericola, Janibacter, Microbacterium, Mycobacterium, Ornithinimicrobium, Pseudonocardia, Rhodococcus, Streptomyces, and Tessaracoccus. Also, one isolate could not be consistently classified and formed a novel phylogenetic branch related to the Nocardiopsaceae family. The antimicrobial activity of these isolates was evaluated, demonstrating the capability of specific novel isolates to inhibit the growth of Gram-positive and Gram-negative bacteria. In conclusion, this study shows a rich biodiversity of culturable Actinobacteria, associated to marine sediments from Valparaíso bay, highlighting novel rare Actinobacteria, and their potential for the production of biologically active compounds.Entities:
Keywords: Nocardiopsaceae; Valparaiso bay; antimicrobial activity; marine Actinobacteria; phylogenetic diversity
Year: 2015 PMID: 26284034 PMCID: PMC4516979 DOI: 10.3389/fmicb.2015.00737
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Map showing the sampling locations. Map of Chile. Boxed region is enlarged in the left bottom panel to emphasize the Valparaíso Region and boxed region is enlarged in the right panel to emphasize the sampling sites located near Punta Ángeles Lighthouse and Torpederas Beach.
Figure 2Diversity of culturable Actinobacteria from Valparaíso. (A) Pie chart representation of the percentage frequency of actinobacterial genera within the total number of isolates. (B) Number of actinobacterial isolates according to the culture media used.
Figure 3Phylogenetic tree of actinobacterial isolates from Valparaíso bay that belong to the suborders . The tree was constructed based on the V1 to V9 region of the 16S rRNA gene sequences using the neighbor-joining method with the percentage of bootstrap replicates (1000 resamplings) supporting the proposed branching order shown at consistent nodes (values below 50% not shown). Gene sequence positions 101–1426 were considered, according to the Escherichia coli K12 16S rRNA gene sequence numbering. Arrow points to the outgroup E. coli K12 (AP012306). The GenBank accession numbers of 16S rRNA sequences are given in parentheses. Scale bar corresponds to 0.01 substitutions per nucleotide positions.
Antimicrobial activity of streptomycete-like strains.
| VH47-3 | MA | − | − | − | − | − | |
| ISP2 | +∕− | − | − | − | + | ||
| ISP3 | − | − | − | − | − | ||
| TSA | − | − | − | − | − | ||
| VA42-3 | MA | − | − | − | − | − | |
| ISP2 | +∕− | − | − | − | − | ||
| ISP3 | − | − | − | − | − | ||
| TSA | − | − | − | − | − | ||
| VS4-2 | MA | − | +∕− | − | − | + | |
| ISP2 | +∕− | +∕− | − | +∕− | +∕− | ||
| ISP3 | − | − | − | − | − | ||
| TSA | − | − | − | − | − | ||
| VO36-3 | MA | − | − | − | − | − | |
| ISP2 | +∕− | +∕− | − | − | − | ||
| ISP3 | − | − | − | − | − | ||
| TSA | − | +∕− | − | − | +++ | ||
| VN6-2 | MA | − | − | − | +++ | +++ | |
| ISP2 | − | +∕− | − | − | +∕− | ||
| ISP3 | − | − | − | − | − | ||
| TSA | − | ++ | +∕− | +++ | +++ | ||
SAEN, Salmonella enterica; STAU, Staphylococcus aureus; PSAU, Pseudomonas aeruginosa; ECO, Escherichia coli; LIMO, Listeria monocytogenes; −, no inhibition; +∕−, attenuated growth of test strain; +, < 50% growth inhibition; ++, 50% growth inhibition; +++, >50% growth inhibition. Media ISP2, ISP3, and TSA were prepared with ASW.
Antimicrobial activity of non streptomycete-like strains.
| VI37-3 | ISP2 | nd | +∕− | nd | − | − | |
| (X79290) (99.92) | TSA | − | − | − | − | +∕− | |
| VP3-3 | ISP2 | nd | ++ | nd | + | ++ | |
| (AB489222) (99.15) | TSA | − | +∕− | − | + | +∕− | |
| VA16-3 | ISP2 | − | − | − | − | − | |
| (X55601) (99.50) | TSA | − | − | − | − | − | |
| VR16-3 | ISP2 | NG | |||||
| (AY522568) (99.58) | TSA | − | +∕− | − | − | − | |
| VP2-3 | ISP2 | nd | +∕− | nd | − | +++ | |
| (EF623999) (98.56) | TSA | − | +∕− | − | − | +∕− | |
| VO29-3 | ISP2 | − | +∕− | +∕− | − | − | |
| (CP001802) (99.01) | TSA | − | +∕− | − | − | ++ | |
| VN12-3 | ISP2 | nd | +∕− | nd | − | +∕− | |
| (AY636111) (99.78) | TSA | − | − | − | − | − | |
| VR7-2 | ISP2 | NG | |||||
| (AB537169) (99.63) | TSA | − | +∕− | − | − | − | |
| VO30-3 | ISP2 | − | − | − | − | − | |
| (CP002379) (99.92) | TSA | +∕− | + | − | +++ | +++ | |
| VP22-3 | ISP2 | − | − | − | − | − | |
| (AY602219) (98.31) | TSA | − | − | − | + | − | |
| VA37-3 | ISP2 | NG | |||||
| (DQ219354) (97.63) | TSA | − | − | − | − | − | |
| V040-3 | ISP2 | − | ++ | − | − | ++ | |
| (AY822044) (99.08) | TSA | +∕− | ++ | +∕− | +∕− | ++ | |
| VH49-3 | ISP2 | NG | |||||
| (KC251737) (99.85) | TSA | − | − | − | − | − | |
| VA9-2 | ISP2 | − | − | − | − | − | |
| (AB279548) (98.90) | TSA | − | − | − | − | +∕− | |
| VD18-3 | ISP2 | NG | |||||
| (AM393882) (99.64) | TSA | − | − | − | − | +∕− | |
SAEN, Salmonella enterica; STAU, Staphylococcus aureus; PSAU, Pseudomonas aeruginosa; ECO, Escherichia coli; LIMO, Listeria monocytogenes; −, no inhibition; +∕−, attenuated growth of test strain; +, < 50% growth inhibition; ++, 50% growth inhibition; +++, >50% growth inhibition. nd, not determined; NG, no growth. Media ISP2 and TSA were prepared with ASW.